SURVIVAL AND TOXICITY UPDATE OF THE PHASE 2 TRIAL OF BEVACIZUMAB (BV) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) PATIENTS

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Desjardins, A; Reardon, DA; Peters, KB; II, HJE; Kirkpatrick, JP; Friedman, HS; Vredenburgh, JJ

Published Date

  • November 2010

Published In

Volume / Issue

  • 12 /

Start / End Page

  • 77 - 77

International Standard Serial Number (ISSN)

  • 1522-8517